Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fluidigm Corporation
(NQ:
FLDM
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 5, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
3.720 (1)
Ask (Size)
3.990 (1)
Prev. Close
3.710
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
378,860,686
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why SomaLogic Stock Dived by 10% on Wednesday
October 04, 2023
The market wasn't impressed by the company's announced tie-up with Standard BioTools.
Via
The Motley Fool
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Via
Benzinga
Exposures
COVID-19
Performance
More News
Read More
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Via
Benzinga
Unusual Options Activity Insight: Fluidigm
August 04, 2021
Via
Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
Via
Benzinga
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
Via
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Via
Benzinga
52 Biggest Movers From Friday
January 31, 2022
Via
Benzinga
28 Stocks Moving In Tuesday's Mid-Day Session
January 25, 2022
Via
Benzinga
Casdin Capital, Viking Global Investors Inject $250M In Fluidigm
January 24, 2022
Via
Benzinga
Fluidigm Shares Gain As Preliminary Q4, FY21 Sales Exceed Expectations
January 11, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
Via
Benzinga
Fluidigm Q3 Sales Trail Estimates; Cuts Annual Guidance As COVID-19 Sales Retreat
November 09, 2021
Via
Benzinga
Exposures
COVID-19
Return on Capital Employed Insights for Fluidigm
August 31, 2021
Via
Benzinga
Fluidigm Q2 Earnings Ahead Of Street Expectations, But Sees Lower Revenues From COVID-19 Products
August 06, 2021
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Thursday's After-Market Session
August 05, 2021
Via
Benzinga
Ultivue Announces Co-Marketing Agreement with Fluidigm for Biomarker Imaging Solutions for Precision Medicine
August 05, 2021
From
Ultivue, Inc.
Via
Business Wire
62 Biggest Movers From Yesterday
July 29, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Fluidigm Stock Shoots Higher On Bloomberg Report Of Exploring Potential Sale
July 28, 2021
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
July 28, 2021
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 11, 2021
Via
Benzinga
56 Biggest Movers From Yesterday
May 12, 2021
Via
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
May 11, 2021
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 07, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
